Laboratory and clinical experience with oral pregneninolone

被引：6

作者：

Cohen, MR ^{[1
]}

Stein, IF ^{[1
]}

机构：

[1] Michael Reese Hosp, Res Dept, Samuel A Deutsch Serum Ctr, Dept Obstet & Gynecol, Chicago, IL USA

来源：

关键词：

D O I：

10.1016/S0002-9378(40)91263-7

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：713 / 724

页数：12

共 13 条

[1] ASTWOOD E. B., 1939, JOUR ENDOCRINOL, V1, P49, DOI 10.1677/joe.0.0010049
[2] Clauberg C., 1938, ZBL GYN, V62, P1745
[3] Courrier R, 1939, CR SOC BIOL, V130, P1162
[4] Multiple activities of anhydro-oxy-progesterone
Emmens, CW
Parkes, AS
[J]. NATURE, 1939, 143 : 1064 - 1064
[5] EMMENS CW, 1939, J ENDOCRINOL, V1, P23
[6] Progesterone is androgenic
Greene, RR
Burrill, MW
Ivy, AC
[J]. ENDOCRINOLOGY, 1939, 24 (03) : 351 - 357
[7] Oral use of pregneninonol in functional meno-metrorrhagia
Hamblen, EC
Powell, NB
Cuyler, WK
Pattee, CT
[J]. ENDOCRINOLOGY, 1940, 26 (02) : 201 - 207
[8] HOHLWEG WALTER, 1939, KLIN WOCHENSCHR, V18, P77, DOI 10.1007/BF01773828
[9] New per os-effective female hipofisis gland hormone derivatives: 17-aethinyl-oesteridol and pregnen-in-on-3-ol-17.
Inhoffen, HH
Hohlweg, W
[J]. NATURWISSENSCHAFTEN, 1938, 26 : 96 - 96
[10] RUZICKA L, 1938, HELV CHIM ACTA, V21, P372